Jesse Watters: Here's why Trump probably hasn't been told anything about Area 51

What does Trump know about Area 51, the Five asks What does Trump know about Area 51, the Five asks Ahead of a Facebook-advertised "storming" of Area 51, Jesse Watters considered whether President Trump has been told about what goes on at the secretive military installation. If Trump is privy to top-secret information about the base, which has long been […]

Read more

A $50b lost opportunity: Why businesses are investing less in the economy

A key insight of economics is that economies go through both short-term "cyclical" changes — the boom and bust cycle — and more deep-seated “structural” shifts. The distinction sounds academic, but it matters for how governments respond to a problem. Dealing with a structural change requires a different response to managing the ups and downs of the business cycle by […]

Read more

Why Alteryx Stock Popped (Again) Today

What happened Shares of Alteryx (NYSE: AYX) were up 10.5% today — the company's second notable single-day jump this week, with the first coming after industry peer Tableau Software agreed to be acquired by Salesforce.com on Monday — as multiple analysts weighed in with positive notes on the data-science and analytics specialist following its annual customer conference. Continue Reading Below […]

Read more

Why Shares of Casey's General Stores Are Climbing on Tuesday

What happened Shares of Casey's General Stores (NASDAQ: CASY) traded up 10% on Tuesday after the convenience and gasoline store operator reported quarterly results that beat expectations and expressed confidence heading into its new fiscal year. Continue Reading Below So what After markets closed Monday, Casey's announced fiscal fourth-quarter earnings of $0.68 per share on revenue of $2.18 billion, beating […]

Read more

Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today

What happened Shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) were shooting 18.9% higher as of 10:57 a.m. EDT on Tuesday. The big jump came after the biotech announced that it received a new patent for treating autism spectrum disorders using synthetic cannabidiol (CBD). Continue Reading Below So what Any patent victories for biotechs focusing on the development of cannabinoid drugs are […]

Read more

Why Take-Two Interactive Stock Climbed 12% in May

What happened Shares of Take-Two Interactive (NASDAQ: TTWO) gained 11.7% last month, according to data provided by S&P Global Market Intelligence. Continue Reading Below The company reported revenue below analysts' estimates and issued lower-than-expected guidance for the fiscal first quarter, but investors overlooked that shortfall. The stock was hammered in late 2018, so there were low expectations baked in to […]

Read more

Why Wabtec Shares Fell Nearly 16% in May

What happened Shares in rail technology company Wabtec (NYSE: WAB) declined 15.8% in May, according to data provided by S&P Global Market Intelligence. Continue Reading Below It's most likely down to some market skepticism regarding the economic outlook. As the economy goes, so goes the transportation sector, and when railroads start feeling the pressure, the first thing they do is […]

Read more

Why JPMorgan Chase CEO Jamie Dimon compares his bank to Netflix

JPMorgan’s Dimon not seeing a recession in next couple years JPMorgan Chase CEO Jamie Dimon on concerns over technology’s impact on the job market, the state of the U.S. economy and the rise in capital expenditures. In a bid to oppose the idea that banks have volatile financial results, JPMorgan Chase CEO Jamie Dimon says investors should think about his […]

Read more
1 2 3 48